ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Legal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

31,811Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 24

$1.96M Total Retail Price of All Prescriptions

Rank: 1 out of 24

698 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 698 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

22% of this provider’s 698 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 25,601 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

46 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LEVOTHYROXINE SODIUM 1,301 1,093 1 2
FUROSEMIDE 1,176 1,069 2 4
HYDROCODONE-ACETAMINOPHEN 877 492 S3 3 8
METOPROLOL TARTRATE 858 731 4 6
OMEPRAZOLE 805 605 5 7
WARFARIN SODIUM 757 698 6 11
PANTOPRAZOLE SODIUM 739 663 7 20
FAMOTIDINE 660 530 8 15
METFORMIN HCL 580 459 9 9
ATORVASTATIN CALCIUM 576 510 10 10
SPIRONOLACTONE 564 499 11 37
SIMVASTATIN 531 480 12 1
DONEPEZIL HCL 519 519 13 24
AMLODIPINE BESYLATE 514 402 14 3
LISINOPRIL 510 437 15 5
POTASSIUM CHLORIDE 411 367 16 13
NAMENDA 388 377 17 41
HYDRALAZINE HCL 386 317 18 38
DIGOXIN 383 376 19 33
FLUTICASONE PROPIONATE 351 231 20 45
TAMSULOSIN HCL 347 302 21 30
LEVETIRACETAM 342 289 22 51
CRESTOR 337 233 23 28
ALENDRONATE SODIUM 328 288 24 21
METOPROLOL SUCCINATE 327 309 25 12
LEVOFLOXACIN 299 233 26 49
MIRTAZAPINE 289 275 27 56
MELOXICAM 274 230 28 52
ENALAPRIL MALEATE 254 206 29 16
CARVEDILOL 252 195 30 17
GABAPENTIN 247 168 31 32
CLOPIDOGREL 245 210 32 22
CLONIDINE HCL 223 99 33 44
JANUVIA 223 195 33 48
PLAVIX 220 195 35 43
SINGULAIR 220 153 35 50
CITALOPRAM HBR 215 153 37 47
ESCITALOPRAM OXALATE 205 191 38 59
ZOLPIDEM TARTRATE 202 151 39 35
GLIMEPIRIDE 201 170 40 26
ALLOPURINOL 197 158 41 23
AMIODARONE HCL 179 174 42 60
PRAVASTATIN SODIUM 176 165 43 19
AMOX TR-POTASSIUM CLAVULANATE 175 100 44 73
AZITHROMYCIN 173 103 45 36
SERTRALINE HCL 170 135 46 40
PREDNISONE 166 114 47 31
CYMBALTA 166 138 47 65
LIDODERM 165 156 49 79
GLIPIZIDE 164 133 50 42
LEVEMIR 161 155 51 82
CARBIDOPA-LEVODOPA 146 140 52 62
ALBUTEROL SULFATE 146 67 52 86
COLCRYS 144 122 54 88
HYDROCHLOROTHIAZIDE 142 102 55 14
OXYBUTYNIN CHLORIDE ER 134 121 56 68
ADVAIR DISKUS 132 79 57 91
MONTELUKAST SODIUM 128 87 58 92
METOLAZONE 127 118 59 93
KLOR-CON M20 123 82 60 66
HYDROXYZINE HCL 121 95 R 61 95
IBUPROFEN 119 72 62 46
TRIAMCINOLONE ACETONIDE 115 93 63 96
SYMBICORT 113 66 64 97
MECLIZINE HCL 113 91 64 97
SPIRIVA 112 55 66 74
IPRATROPIUM BROMIDE 112 39 66 99
CLOTRIMAZOLE-BETAMETHASONE 112 97 66 72
PROAIR HFA 111 85 69 57
TRAMADOL HCL 111 84 69 18
QUETIAPINE FUMARATE 110 102 71 77
LYRICA 108 85 72 77
CELEBREX 106 85 73 82
FENOFIBRATE 105 76 74 82
NIFEDIPINE ER 104 90 75 53
IPRATROPIUM-ALBUTEROL 103 90 76 102
PATANOL 103 92 76 102
NOVOLIN R 102 84 78 104
NITROGLYCERIN PATCH 99 92 79 106
VESICARE 99 95 79 106
LANTUS 99 75 79 58
NABUMETONE 98 68 82 85
LIPITOR 98 74 82 108
SULFAMETHOXAZOLE-TRIMETHOPRIM 94 70 84 110
LOSARTAN POTASSIUM 94 89 84 27
TRAZODONE HCL 92 50 86 111
NOVOLOG 92 76 86 111
EXELON 92 82 86 111
DOXYCYCLINE HYCLATE 89 61 89 115
FINASTERIDE 88 85 90 116
DIOVAN 87 58 91 39
FLECTOR 85 82 92 118
ATENOLOL 82 71 93 25
LANTUS SOLOSTAR 82 65 93 120
SANTYL 81 75 95 121
METOCLOPRAMIDE HCL 80 46 96 122
INSULIN SYRINGE 80 64 96 122
LEXAPRO 79 64 98 126
BACLOFEN 78 45 99 89
VOLTAREN 77 69 100 81
HYDROMORPHONE HCL 76 70 S2 101 127
NYSTATIN 76 70 101 127
NYSTOP 74 62 103 131
AMITRIPTYLINE HCL 74 57 R 103 67
NEXIUM 72 37 105 71
BYSTOLIC 72 52 105 80
LOVASTATIN 71 48 107 34
TRILIPIX 68 49 108 135
DILTIAZEM 24HR ER 65 64 109 140
ONDANSETRON HCL 64 40 110 141
TRIAMTERENE-HCTZ 63 45 111 63
ABILIFY 63 58 111 142
KLOR-CON 10 62 49 113 87
VENTOLIN HFA 61 13 114 90
BUDESONIDE 59 40 115 147
NOVOLIN 70-30 59 29 115 147
TOPIRAMATE 58 29 117 151
ACETAMINOPHEN-CODEINE 58 47 S3 117 74
ISOSORBIDE MONONITRATE ER 57 53 119 60
RISPERIDONE 56 47 120 94
BUSPIRONE HCL 56 43 120 154
ROPINIROLE HCL 55 43 122 155
FENTANYL 55 29 S2 122 100
DIVALPROEX SODIUM ER 54 34 124 158
METHIMAZOLE 54 39 124 158
POLYETHYLENE GLYCOL 3350 54 37 124 158
PAROXETINE HCL 53 32 127 162
PRANDIN 52 52 128 163
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 11, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.